does blue cross blue shield pay for glp 1 obesity #tippingpointinobesitycare #joenadglowski #oac #jennyseger #mickeyseger #chrisgallagher #oma #theobesitysociety #asmbs #lilly #novonordisk #boehringeringelheim #pfizer | Deborah Bade Horn Blue Cross Blue Shield of

The takeaway: GLP-1s are just one cost driver the real focus for HR is helping employees manage healthcare spending with the tools available

Notably, in STZ-induced T2D mice, LEO intervention not only dose-dependently improved oral glucose tolerance (Figure 1B) but also significantly elevated GLP-1 levels in serum and colonic tissues

Mayer-Davis EJ, Rifas-Shiman SL, Zhou L, et al

Diagnosis rate impact by condition among female GLP-1 utilizers of Mounjaro, Ozempic, Wegovy, and Zepbound during first 24 months compared to control Note: All comparisons are at a 99% confidence interval Inpatient admission by condition among female GLP-1 utilizers of Mounjaro, Ozempic, Wegovy, and Zepbound during first 24 months compared to control Note: All comparisons are at a 99% confidence interval The Importance of Adherence Across both diabetes and weight loss cohorts, adherence to GLP-1 therapy at 80% or higher amplifies cost benefits